NL300663I2 - - Google Patents
Download PDFInfo
- Publication number
- NL300663I2 NL300663I2 NL300663C NL300663C NL300663I2 NL 300663 I2 NL300663 I2 NL 300663I2 NL 300663 C NL300663 C NL 300663C NL 300663 C NL300663 C NL 300663C NL 300663 I2 NL300663 I2 NL 300663I2
- Authority
- NL
- Netherlands
- Prior art keywords
- recombinant
- multimodal
- potency
- purifying
- purification
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 3
- 102000015081 Blood Coagulation Factors Human genes 0.000 abstract 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 abstract 1
- 102000001690 Factor VIII Human genes 0.000 abstract 1
- 108010054218 Factor VIII Proteins 0.000 abstract 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 239000003114 blood coagulation factor Substances 0.000 abstract 1
- 229960000301 factor viii Drugs 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07112287 | 2007-07-11 | ||
| PCT/EP2008/059094 WO2009007451A1 (en) | 2007-07-11 | 2008-07-11 | Purification of factor viii using a mixed-mode or multimodal resin |
| EP08786090A EP2167526B1 (en) | 2007-07-11 | 2008-07-11 | Purification of factor viii using a mixed-mode or multimodal resin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL300663I2 true NL300663I2 (nl) | 2016-09-22 |
Family
ID=38472947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL300663C NL300663I2 (nl) | 2007-07-11 | 2014-04-15 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8399620B2 (nl) |
| EP (1) | EP2167526B1 (nl) |
| JP (1) | JP5323072B2 (nl) |
| KR (1) | KR101293504B1 (nl) |
| CN (1) | CN101730707B (nl) |
| AT (1) | ATE503763T1 (nl) |
| AU (1) | AU2008274195B2 (nl) |
| BR (1) | BRPI0814220B8 (nl) |
| CA (1) | CA2692814A1 (nl) |
| DE (1) | DE602008005885D1 (nl) |
| ES (1) | ES2364118T3 (nl) |
| NL (1) | NL300663I2 (nl) |
| PL (1) | PL2167526T3 (nl) |
| RU (1) | RU2493163C2 (nl) |
| WO (1) | WO2009007451A1 (nl) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009156430A1 (en) | 2008-06-24 | 2009-12-30 | Octapharma Ag | A process of purifying coagulation factor viii |
| US9120873B2 (en) | 2008-08-21 | 2015-09-01 | Octapharma Ag | Recombinantly produced human factor VIII and IX |
| US8945895B2 (en) | 2009-07-31 | 2015-02-03 | Baxter International Inc. | Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof |
| US8277649B2 (en) | 2009-12-14 | 2012-10-02 | General Electric Company | Membranes and associated methods for purification of antibodies |
| EP2538968B1 (en) * | 2010-02-24 | 2017-11-01 | Chiesi Farmaceutici S.p.A. | Process for production and purification of recombinant lysosomal alpha-mannosidase |
| MX2012011065A (es) | 2010-03-30 | 2012-10-10 | Octapharma Ag | Proceso para purificacion de proteina de factor de crecimiento. |
| EP3133157B1 (en) | 2010-03-30 | 2019-05-08 | Octapharma AG | A process for purifying vitamin k dependent proteins |
| BR112013007237A2 (pt) | 2010-11-05 | 2016-06-14 | Hoffmann La Roche | ''método para produzir um anticorpo anti-ig-1r'' |
| WO2012082933A1 (en) | 2010-12-15 | 2012-06-21 | Baxter International, Inc. | Eluate collection using conductivity gradient |
| WO2013075740A1 (en) | 2011-11-23 | 2013-05-30 | Sanofi | Antibody purification method |
| US20150275195A1 (en) | 2012-10-24 | 2015-10-01 | Genzyme Corporation | Elution of biomolecules from multi-modal resins using mes and mops as mobile phase modifiers |
| US10188965B2 (en) | 2012-12-05 | 2019-01-29 | Csl Behring Gmbh | Hydrophobic charge induction chromatographic depletion of a protein from a solution |
| US20140154233A1 (en) | 2012-12-05 | 2014-06-05 | Csl Limited | Method of purifying therapeutic proteins |
| CN103396494B (zh) * | 2013-04-27 | 2015-04-01 | 江苏省疾病预防控制中心 | 一种凝血因子ix的单克隆抗体 |
| JP6463734B2 (ja) * | 2013-05-06 | 2019-02-06 | サノフイＳａｎｏｆｉ | 抗体を精製するための連続的多工程法 |
| TW201617360A (zh) * | 2014-06-25 | 2016-05-16 | 桂格 史考特 布蘭克 | 用於純化蛋白質之方法及試劑 |
| WO2016020210A1 (en) | 2014-08-04 | 2016-02-11 | Csl Behring Gmbh | Csl behring gmbh |
| CN107406493B (zh) | 2015-03-06 | 2021-08-13 | 康诺贝林伦瑙有限公司 | 具有改善的半衰期的经修饰的血管性血友病因子 |
| GB201506117D0 (en) | 2015-04-10 | 2015-05-27 | Ge Healthcare Bio Sciences Ab | Method for chromatography |
| GB201506113D0 (en) * | 2015-04-10 | 2015-05-27 | Ge Healthcare Bio Sciences Ab | Method for chromatography |
| EP3205665A1 (en) * | 2016-02-11 | 2017-08-16 | Octapharma AG | Method of separating factor viii from blood products |
| GB201617240D0 (en) * | 2016-10-11 | 2016-11-23 | Profactor Pharma Ltd | Purification process |
| US11299533B2 (en) | 2017-06-23 | 2022-04-12 | Takeda Pharmaceutical Company Limited | Purification of factor VIII subspecies |
| EP3546475A1 (en) | 2018-03-27 | 2019-10-02 | Sanofi | Full flow-through process for purifying recombinant proteins |
| KR20220029733A (ko) | 2019-07-04 | 2022-03-08 | 체에스엘 베링 렝나우 아게 | 응고 인자 viii의 시험관내 안정성을 증가시키기 위한 절단된 폰 빌레브란트 인자 (vwf) |
| WO2021094344A1 (en) | 2019-11-11 | 2021-05-20 | CSL Behring Lengnau AG | Polypeptides for inducing tolerance to factor viii |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9302006D0 (sv) * | 1992-10-02 | 1993-06-11 | Kabi Pharmacia Ab | Protein formulation |
| SE9301581D0 (sv) * | 1993-05-07 | 1993-05-07 | Kabi Pharmacia Ab | Protein formulation |
| SE503424C2 (sv) | 1994-11-14 | 1996-06-10 | Pharmacia Ab | Process för rening av rekombinant koagulationsfaktor VIII |
| IL157309A0 (en) * | 2003-08-07 | 2004-02-19 | Applied Research Systems | Method for the purification of a non-immunoglobulin protein |
| EP2360171A1 (en) * | 2004-12-23 | 2011-08-24 | Novo Nordisk Health Care AG | Reduction of the content of protein contaminants in compositions comprising a vitamin K-dependent protein of interest |
| EP1707634A1 (en) | 2005-03-29 | 2006-10-04 | Octapharma AG | Method for isolation of recombinantly produced proteins |
| WO2009156430A1 (en) | 2008-06-24 | 2009-12-30 | Octapharma Ag | A process of purifying coagulation factor viii |
-
2008
- 2008-07-11 KR KR1020107001510A patent/KR101293504B1/ko not_active Expired - Fee Related
- 2008-07-11 ES ES08786090T patent/ES2364118T3/es active Active
- 2008-07-11 JP JP2010515524A patent/JP5323072B2/ja active Active
- 2008-07-11 CA CA 2692814 patent/CA2692814A1/en not_active Abandoned
- 2008-07-11 WO PCT/EP2008/059094 patent/WO2009007451A1/en not_active Ceased
- 2008-07-11 CN CN200880023645.XA patent/CN101730707B/zh active Active
- 2008-07-11 AU AU2008274195A patent/AU2008274195B2/en not_active Ceased
- 2008-07-11 DE DE602008005885T patent/DE602008005885D1/de active Active
- 2008-07-11 PL PL08786090T patent/PL2167526T3/pl unknown
- 2008-07-11 RU RU2010103528/10A patent/RU2493163C2/ru active
- 2008-07-11 BR BRPI0814220A patent/BRPI0814220B8/pt not_active IP Right Cessation
- 2008-07-11 US US12/668,530 patent/US8399620B2/en active Active
- 2008-07-11 EP EP08786090A patent/EP2167526B1/en active Active
- 2008-07-11 AT AT08786090T patent/ATE503763T1/de not_active IP Right Cessation
-
2014
- 2014-04-15 NL NL300663C patent/NL300663I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101730707A (zh) | 2010-06-09 |
| JP5323072B2 (ja) | 2013-10-23 |
| ATE503763T1 (de) | 2011-04-15 |
| US8399620B2 (en) | 2013-03-19 |
| ES2364118T3 (es) | 2011-08-25 |
| CN101730707B (zh) | 2014-12-17 |
| DE602008005885D1 (de) | 2011-05-12 |
| PL2167526T3 (pl) | 2011-09-30 |
| WO2009007451A1 (en) | 2009-01-15 |
| BRPI0814220A2 (pt) | 2015-01-06 |
| RU2493163C2 (ru) | 2013-09-20 |
| KR20100051620A (ko) | 2010-05-17 |
| EP2167526A1 (en) | 2010-03-31 |
| EP2167526B1 (en) | 2011-03-30 |
| CA2692814A1 (en) | 2009-01-15 |
| ES2364118T9 (es) | 2014-05-19 |
| AU2008274195A1 (en) | 2009-01-15 |
| KR101293504B1 (ko) | 2013-08-07 |
| AU2008274195B2 (en) | 2013-09-05 |
| JP2010533150A (ja) | 2010-10-21 |
| RU2010103528A (ru) | 2011-08-20 |
| BRPI0814220B1 (pt) | 2019-09-17 |
| US20100204452A1 (en) | 2010-08-12 |
| BRPI0814220B8 (pt) | 2021-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300663I2 (nl) | ||
| MX2018014395A (es) | Aislamiento y purificacion de anticuerpos usando la cromatografia de afinidad de proteina a. | |
| AU2008301614A8 (en) | Mutant pyrrolysyl-tRNA synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same | |
| MX341136B (es) | Aislamiento y purificacion de los anticuerpos anti-il-13 al usar la cromatografia de afinidad con proteina a. | |
| WO2010129304A3 (en) | Method for making heteromultimeric molecules | |
| AU2017263237A1 (en) | GDF15 fusion proteins and uses thereof | |
| MX2010005783A (es) | Secuencias de aminoacidos dirigidas contra citoquinas heterodimericas y/o sus receptores y polipeptidos que comprenden las mismas. | |
| IL226717A (en) | Isolated nucleic acids encoded by anti-beta human antibodies 7 | |
| WO2007104529A3 (en) | Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling | |
| WO2020198264A8 (en) | Modified cleavases, uses thereof and related kits | |
| MX2010002769A (es) | Preparacion recombinante de fracciones de bromelaina seleccionadas. | |
| WO2010142551A8 (en) | Amino acid sequences directed against receptors to cytokines belonging to the il-17 family | |
| MX2008012748A (es) | Un proceso para la concentracion de un polipeptido. | |
| MX2015008875A (es) | Metodos para la purificacion de arilsulfatasa a. | |
| IL172729A0 (en) | Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins | |
| MY151330A (en) | Systems and method for separating proteins from connective tissue | |
| DE502004007067D1 (de) | Verfahren zur herstellung zyklischer moleküle | |
| WO2010040736A3 (en) | Amino acid sequences directed against il18 and/or the il-18 receptor and polypeptides comprising the same for the treatment of diseases and/or disorders associated with il-18 mediated signaling | |
| EP3956347A4 (en) | DAF-MCP CHIMERIC PROTEINS, THEIR MANUFACTURING METHOD AND USE OF THE CHIMERIC PROTEIN TO TREAT PATHOLOGICAL CONDITIONS INVOLVING THE COMPLEMENT SYSTEM | |
| GB2469395A (en) | Methods and compounds for phototransfer | |
| ZA202304030B (en) | Modified cxcl10 for immunotherapy of cancer diseases | |
| EP4118093A4 (en) | METHOD FOR PURIFYING A FC FUSION PROTEIN | |
| EP4169938A4 (en) | RECOMBINANT PROTEIN PURIFICATION METHOD | |
| WO2009083968A8 (en) | Novel protein | |
| IL284402A (en) | A process for the production, isolation and purification of modified recombinant proteins |